Patent ID: 7842713
Filing Date: 2010-11-30
Classification: A61P,C07D

Abstract:
1. A compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein: Ring A is (4-12)-membered heterocyclyl; Ring B is a fused benzene ring selected from the group consisting of: wherein in each of the above formula B(i) and B(ii), bond a is connecting said ring B fused benzene ring to the group -L Each R Ring C contains an optional double bond and an optional heteroatom selected from the group consisting of —O—, —NR each of R R L R R each of R any carbon atoms of the (C any carbon atoms of the (C any nitrogen atoms of the (4-10)-membered heterocyclyl of the foregoing R each R R p, q, and v are each independently 0, 1, 2, 3, 4, or 5; w, n and j are each independently 0, 1, or 2; k is 1 or 2; and t and z are each independently 1, 2, 3, or 4; with the proviso that when compound (I) has the formula: wherein Ring A is pyridin-2-yl or thiazol-2-yl; L R R